Return to search

ImmunOs Therapeutics picks up Series B

ImmunOs Therapeutics AG, a biopharmaceutical company, has raised $74 million in Series B financing.

ImmunOs Therapeutics AG, a biopharmaceutical company, has raised $74 million in Series B financing. Samsara BioCapital, Lightspeed Venture Partners and Gimv led the round.

Source: Press Release